As Ethan Berke, MD, MPH, Chief Medical Officer at Teladoc Health, put it perfectly: When something new comes in, we dont always know how to use it
It is a more intentional choice for women who want better nutritional support during GLP-1 treatment, not just a generic formula with a marketing label
Get the full episode here: Cartier, Elizabeth, and host Wayne Pines dived deep into FDAs maintenance of its drug review process, the agencys new PreCheck program, FDAs evolving stance on confirmatory evidence and accelerated approvals, agency budgets, and more
The PlexusDx Precision Peptide Genetic Test analyzes GLP1R (rs6923761), GIPR (rs1800437), and FTO (rs9939609) variants that relate to GLP-1 and related signaling pathways
This limitation partially compromises the comparability of study results and the reliability of clinical applications